fbpx

See If You Qualify For The vacc-gsk-mat Research Trial

The purpose of this research study is to evaluate the lot to lot safety consistency of RSV maternal vaccine and to evaluate the reactogenicity and immunogenicity of a single intramuscular dose of GSK Biologicals’ investigational RSV maternal vaccine given alone or in co-administration with a single intramuscular dose of seasonal influenza vaccine D-QIV.

Qualified Participants will receive:

  •  Study-related vaccine at no cost
  •  Study-related medical exams at no cost
  •  Compensation up to $250 for time and travel
3 EASY STEPS

How It Works

Step 1

Step 1

Fill out the form to instantly see if you qualify. You can also give us a call at 561-689-0606.
Step 2

Step 2

A member of our team will reach out shortly and may ask some additional questions. 
Step 3

Step 3

If you’re qualified, you will have the opportunity to schedule an office visit for an exam. 
Vaccine for anyone over age 60

Vaccine for anyone over age 60

The purpose of this research study is to demonstrate the efficacy of a single dose of GSK’s RSVPreF3 OA investigational vaccine in adults aged 60 years and above.

RSV (Common Cold)

RSV (Common Cold)

This research study is to evaluate the effectiveness and safety of an oral investigational medication for the treatment of Acute Upper Respiratory Infection.

MIGRAINE ?

MIGRAINE ?

The purpose of this research study is to demonstrate the efficacy, safety, and tolerability of STS101 (Dihydroergotamine Nasal Powder) in the acute treatment of Migraines.

Subscribe To Our Newsletter

Subscribe to learn more about our clinical research trials, current and upcoming studies. 

Scroll to Top